Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
United States
Children's Hospital Colorado, Aurora, Colorado Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio Nationwide Children's Hospital, Columbus, Ohio Children's Hospital of Philadelphia, Philadelphia, Pennsylvania